Position in PTGX
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$284,017
+$48,554 QoQ
Shares Held
2,317
+3.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#249
of 341 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHOREO, LLC holds $19,054,830 across 40 Biotechnology names. PTGX ranks #21 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,514 | $3,438,199 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,474 | $3,215,830 | |
| 3 | INCY |
Incyte Corp
|
7,759 | $879,560 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,770 | $833,853 | |
| 5 | ARGX |
Argenx SE
|
809 | $750,565 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
3,045 | $733,753 | |
| 7 | ACAD |
Acadia Pharmaceuticals Inc
|
27,134 | $686,490 | |
| 8 | GMAB |
Genmab A/S
|
24,930 | $684,827 |
All Filings in PTGX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $284,017 | 2,317 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $235,463 | 2,234 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||